Stay updated on Mepolizumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mepolizumab in Chronic Urticaria Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page’s footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:08:57.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.7.1 instead of v3.7.0. The study record page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T13:43:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link in place of the trial details.
    Difference
    0.5%
    Check dated 2026-10-03T14:35:20.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page, and a substantial portion of the study’s documents and metadata (including protocol, investigators, sponsor, drug details, and regulatory notes) were removed, reducing the visible details of the study record.
    Difference
    17%
    Check dated 2026-09-19T18:33:52.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing Revision: v3.6.5, indicating a newer page version was published without changing the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:00:18.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The revision updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a backend/CMS update that does not alter the study details shown on the page.
    Difference
    0.1%
    Check dated 2026-08-08T15:31:02.000Z thumbnail image

Stay in the know with updates to Mepolizumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mepolizumab in Chronic Urticaria Clinical Trial page.